All In Biotech

Drug Trial Radar · NCT07425522

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)

A Phase I, Multicenter, Open-Label, Multiple-Ascending Dose Study of the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 Administered by Intravitreal Injection as Monotherapy and in Combination With Faricimab in Patients With Diabetic Macular Edema

Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

93

Planned (sponsor's estimate)

Start

Apr 21, 2026

Primary completion

Nov 17, 2028

Study completion Nov 17, 2028

Sponsor

Lead sponsor
Genentech, Inc.Roche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Feb 23, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety, tolerability, Pharmacodynamics (PD), and Pharmacokinetics (PK) of multiple doses of RO7823653 in participants with DME, administered by intravitreal (IVT) injection as monotherapy and co-administered with faricimab.

Conditions

  • Diabetic Macular Edema

Interventions

  • RO7823653Drug

    Participants will receive RO7823653 as an IVT injection per the schedule described in the protocol.

  • FaricimabDrug

    Participants will receive faricimab as an IVT injection per the schedule described in the protocol.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Ocular Adverse Events (AEs) and Systemic AEsTime frame: Up to approximately 20 Weeks

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Associated Retina Consultants - Peoria - DocTrials - PPDS

    Peoria, Arizona · Recruiting

  • Retina-Vitreous Associates Medical Group

    Beverly Hills, California · Recruiting

  • Bay Area Retina Specialists Medical Group - Vestrum - PPDS

    Walnut Creek, California · Recruiting

  • Retina Vitreous Associates of Florida

    St. Petersburg, Florida · Recruiting

  • Wilmer Eye Institute

    Baltimore, Maryland · Recruiting

  • Erie Retina Research, LLC - 300 State St

    Erie, Pennsylvania · Recruiting

  • Wills Eye Hospital

    Philadelphia, Pennsylvania · Recruiting

  • Charles Retina Institute

    Germantown, Tennessee · Recruiting

  • Retina Research Institute of Texas

    Abilene, Texas · Recruiting

  • Austin Clinical Research, LLC

    Austin, Texas · Recruiting

  • Retina Consultants of Texas Westover Hills Retina Center

    San Antonio, Texas · Recruiting

  • Piedmont Eye Center

    Lynchburg, Virginia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.